|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 12713680.2 (espacenet) (Federated) (European Patent Register), 20120330 | | Patent/reg. no. and date | DK/EP 2694087, 20150128 | | Publication date | 20140212 | | Priority no. and date | US 201161470666 P, 20110401 | | EP pub. no. and date |
EP 2694087 20140212 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | NGC/AP/150429 | | Inventor | NAOUMOV, Nikolai, c/o Novartis Pharma AG
Postfach
CH-4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/13 (2006.01) , A61P 1/16 (2006.01) , A61P 31/14 (2006.01) , A61P 31/20 (2006.01) | | Title | Behandling af infektion med Hepatitis-B-virus alene eller i kombination med Hepatitis-delta-virus og i forbindelse med leversygdomme | | Int. application no. | EP2012055857 | | Int. publication no. | WO2012131061 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
